Skip to Content
Merck
CN
  • Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1A.

Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1A.

Cell stem cell (2019-08-03)
Fabian L Cardenas-Diaz, Catherine Osorio-Quintero, Maria A Diaz-Miranda, Siddharth Kishore, Karla Leavens, Chintan Jobaliya, Diana Stanescu, Xilma Ortiz-Gonzalez, Christine Yoon, Christopher S Chen, Rachana Haliyur, Marcela Brissova, Alvin C Powers, Deborah L French, Paul Gadue
ABSTRACT

Human monogenic diabetes, caused by mutations in genes involved in beta cell development and function, has been a challenge to study because multiple mouse models have not fully recapitulated the human disease. Here, we use genome edited human embryonic stem cells to understand the most common form of monogenic diabetes, MODY3, caused by mutations in the transcription factor HNF1A. We found that HNF1A is necessary to repress an alpha cell gene expression signature, maintain endocrine cell function, and regulate cellular metabolism. In addition, we identified the human-specific long non-coding RNA, LINKA, as an HNF1A target necessary for normal mitochondrial respiration. These findings provide a possible explanation for the species difference in disease phenotypes observed with HNF1A mutations and offer mechanistic insights into how the HNF1A gene may also influence type 2 diabetes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
SANT-1, ≥98% (HPLC), powder
Sigma-Aldrich
N-Acetyl-L-cysteine, BioReagent, suitable for cell culture
Sigma-Aldrich
γ-Secretase Inhibitor XX, This γ-secretase inhibitor, CAS 209984-56-5, is a cell-permeable dibenzazepine compound that lowers both brain and plasma Aβ40 levels by ~72% in Tg2576 mutant APP transgenic mouse model.